Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 2/2015

01.08.2015 | Gynecologic Endocrinology and Reproductive Medicine

Prophylactic vitamin D supplementation in ovarian hyperstimulation syndrome: an animal study

verfasst von: Guluzar Arzu Turan, Fatma Eskicioglu, Oya Nermin Sivrikoz, Hakan Cengiz, Esra Bahar Gur, Sumeyra Tatar, Nur Sahin, Osman Yilmaz

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the effect of vitamin D in ovarian hyperstimulation syndrome (OHSS).

Methods

In this animal study, 28 immature female Wistar rats were divided into four groups: group 1 (control); group 2 (ovarian stimulation); group 3 (OHSS group); group 4 (OHSS + vitamin D group). All groups were killed 48 h after hCG administration and were compared in terms of vascular permeability, ovarian weight, ovarian diameter, vascular endothelial growth factor (VEGF) expression (immunohistochemistry) in ovarian tissue and pigment epithelium-derived factor (PEDF) level in the serum (ELISA test) with the Kruskal–Wallis and Mann–Whitney U tests.

Results

VEGF expression in the vitamin D group was similar to that in the OHSS group. However, the PEDF level was significantly higher in the vitamin D group (p = 0.013).

Conclusions

Prophylactic vitamin D supplementation is not sufficiently effective in preventing OHSS. Vitamin D effectively increases PEDF, which has an opposing effect on VEGF, which plays a key role in OHSS. Thus, the protective effect of Vitamin D on OHSS should be investigated with a vitamin D deficient model in the study group.
Literatur
2.
Zurück zum Zitat Soares SR, Gómez R, Simón C, García-Velasco JA, Pellicer A (2008) Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Hum Reprod Update 14:321–333CrossRefPubMed Soares SR, Gómez R, Simón C, García-Velasco JA, Pellicer A (2008) Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Hum Reprod Update 14:321–333CrossRefPubMed
3.
Zurück zum Zitat Mathur RS, Jenkins JM, Bansal AS (1997) The possible role of the immune system in the aetiopathogenesis of ovarian hyperstimulation syndrome. Hum Reprod 12:2629–2634CrossRefPubMed Mathur RS, Jenkins JM, Bansal AS (1997) The possible role of the immune system in the aetiopathogenesis of ovarian hyperstimulation syndrome. Hum Reprod 12:2629–2634CrossRefPubMed
4.
Zurück zum Zitat Orvieto R, Achiron A, Margalit R, Ben-Rafael Z (1998) The role of intravenous immunoglobulin in the prevention of severe ovarian hyperstimulation syndrome. J Assist Reprod Genet 15:46–49PubMedCentralCrossRefPubMed Orvieto R, Achiron A, Margalit R, Ben-Rafael Z (1998) The role of intravenous immunoglobulin in the prevention of severe ovarian hyperstimulation syndrome. J Assist Reprod Genet 15:46–49PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Fábregues F, Balasch J, Manau D, Jiménez W, Arroyo V, Creus M, Rivera F, Vanrell JA (1998) Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome. Hum Reprod 13:2406–2410CrossRefPubMed Fábregues F, Balasch J, Manau D, Jiménez W, Arroyo V, Creus M, Rivera F, Vanrell JA (1998) Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome. Hum Reprod 13:2406–2410CrossRefPubMed
6.
Zurück zum Zitat Kosaka K, Fujiwara H, Yoshioka S, Fujii S (2007) Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome. Hum Reprod 22:1647–1651CrossRefPubMed Kosaka K, Fujiwara H, Yoshioka S, Fujii S (2007) Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome. Hum Reprod 22:1647–1651CrossRefPubMed
7.
Zurück zum Zitat Enskog A, Nilsson L, Brännström M (2001) Low peripheral blood levels of the immunosuppressive cytokine interleukin 10 (IL-10) at the start of gonadotrophin stimulation indicates increased risk for development of ovarian hyperstimulation syndrome (OHSS). J Reprod Immunol 49:71–85CrossRefPubMed Enskog A, Nilsson L, Brännström M (2001) Low peripheral blood levels of the immunosuppressive cytokine interleukin 10 (IL-10) at the start of gonadotrophin stimulation indicates increased risk for development of ovarian hyperstimulation syndrome (OHSS). J Reprod Immunol 49:71–85CrossRefPubMed
8.
Zurück zum Zitat Liu X, Chen HH, Zhang LW (2013) Potential therapeutic effects of pigment epithelium-derived factor for treatment of diabetic retinopathy. Int J Ophthalmol 6:221–227PubMedCentralPubMed Liu X, Chen HH, Zhang LW (2013) Potential therapeutic effects of pigment epithelium-derived factor for treatment of diabetic retinopathy. Int J Ophthalmol 6:221–227PubMedCentralPubMed
9.
Zurück zum Zitat Yamagishi S, Abe R, Jinnouchi Y, Matsui T, Imaizumi T, Inoue H (2007) Pigment epithelium-derived factor inhibits vascular endothelial growth factor-induced vascular hyperpermeability both in vitro and in vivo. J Int Med Res 35:896–899CrossRefPubMed Yamagishi S, Abe R, Jinnouchi Y, Matsui T, Imaizumi T, Inoue H (2007) Pigment epithelium-derived factor inhibits vascular endothelial growth factor-induced vascular hyperpermeability both in vitro and in vivo. J Int Med Res 35:896–899CrossRefPubMed
10.
Zurück zum Zitat Yamagishi S, Nakamura K, Matsui T, Inagaki Y, Takenaka K, Jinnouchi Y, Yoshida Y, Matsuura T, Narama I, Motomiya Y et al (2006) Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J Biol Chem 281:20213–20220CrossRefPubMed Yamagishi S, Nakamura K, Matsui T, Inagaki Y, Takenaka K, Jinnouchi Y, Yoshida Y, Matsuura T, Narama I, Motomiya Y et al (2006) Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J Biol Chem 281:20213–20220CrossRefPubMed
11.
Zurück zum Zitat Liu H, Ren JG, Cooper WL, Hawkins CE, Cowan MR, Tong PY (2004) Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site. Proc Natl Acad Sci USA 101:6605–6610PubMedCentralCrossRefPubMed Liu H, Ren JG, Cooper WL, Hawkins CE, Cowan MR, Tong PY (2004) Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site. Proc Natl Acad Sci USA 101:6605–6610PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Gruber HE, Hoelscher G, Ingram JA, Chow Y, Loeffler B, Hanley EN Jr (2008) 1,25(OH)2-vitamin D3 inhibits proliferation and decreases production of monocyte chemoattractant protein-1, thrombopoietin, VEGF, and angiogenin by human annulus cells in vitro. Spine (Phila Pa 1976) 33:755–765 Gruber HE, Hoelscher G, Ingram JA, Chow Y, Loeffler B, Hanley EN Jr (2008) 1,25(OH)2-vitamin D3 inhibits proliferation and decreases production of monocyte chemoattractant protein-1, thrombopoietin, VEGF, and angiogenin by human annulus cells in vitro. Spine (Phila Pa 1976) 33:755–765
13.
Zurück zum Zitat Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE (2000) 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res 87:214–220CrossRefPubMed Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE (2000) 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res 87:214–220CrossRefPubMed
14.
Zurück zum Zitat Chen SF, Ruan YJ (1995) 1 alpha,25-dihydroxyvitamin D3 decreases scalding- and platelet-activating factor-induced high vascular permeability and tissue oedema. Pharmacol Toxicol 76:365–367CrossRefPubMed Chen SF, Ruan YJ (1995) 1 alpha,25-dihydroxyvitamin D3 decreases scalding- and platelet-activating factor-induced high vascular permeability and tissue oedema. Pharmacol Toxicol 76:365–367CrossRefPubMed
16.
Zurück zum Zitat Yazici G, Yildiz F, Iskit A, Erdemli E, Surucu S, Firat P, Hayran M, Ozyigit G, Cengiz M (2011) The effect of vitamin D prophylaxis on radiation induced pulmonary damage. J Radiat Res 52:616–621CrossRefPubMed Yazici G, Yildiz F, Iskit A, Erdemli E, Surucu S, Firat P, Hayran M, Ozyigit G, Cengiz M (2011) The effect of vitamin D prophylaxis on radiation induced pulmonary damage. J Radiat Res 52:616–621CrossRefPubMed
17.
Zurück zum Zitat Huang JYJ, Rosenwaks Z (2010) Preventive strategies of ovarian hyperstimulation syndrome. J Exp Clin Med 2(2):53–62CrossRef Huang JYJ, Rosenwaks Z (2010) Preventive strategies of ovarian hyperstimulation syndrome. J Exp Clin Med 2(2):53–62CrossRef
18.
Zurück zum Zitat Gómez R1, Simón C, Remohí J, Pellicer A (2003) Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability. Biol Reprod 68(6):2164–71 Gómez R1, Simón C, Remohí J, Pellicer A (2003) Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability. Biol Reprod 68(6):2164–71
19.
Zurück zum Zitat Liu JT, Chen YL, Chen WC, Chen HY, Lin YW, Wang SH, Man KM, Wan HM, Yin WH, Liu PL et al (2012) Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization. J Biomed Biotechnol 2012:871272PubMedCentralPubMed Liu JT, Chen YL, Chen WC, Chen HY, Lin YW, Wang SH, Man KM, Wan HM, Yin WH, Liu PL et al (2012) Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization. J Biomed Biotechnol 2012:871272PubMedCentralPubMed
20.
Zurück zum Zitat Chuderland D, Ben-Ami I, Kaplan-Kraicer R, Grossman H, Ron-El R, Shalgi R (2013) The role of pigment epithelium-derived factor in the pathophysiology and treatment of ovarian hyperstimulation syndrome in mice. J Clin Endocrinol Metab 98:E258–E266CrossRefPubMed Chuderland D, Ben-Ami I, Kaplan-Kraicer R, Grossman H, Ron-El R, Shalgi R (2013) The role of pigment epithelium-derived factor in the pathophysiology and treatment of ovarian hyperstimulation syndrome in mice. J Clin Endocrinol Metab 98:E258–E266CrossRefPubMed
21.
Zurück zum Zitat Ocal P, Sahmay S, Cetin M, Irez T, Guralp O, Cepni I (2011) Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles. J Assist Reprod Genet 28:1197–1203PubMedCentralCrossRefPubMed Ocal P, Sahmay S, Cetin M, Irez T, Guralp O, Cepni I (2011) Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles. J Assist Reprod Genet 28:1197–1203PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Wojtusik J, Johnson PA (2012) Vitamin D regulates anti-Mullerian hormone expression in granulosa cells of the hen. Biol Reprod 86:91CrossRefPubMed Wojtusik J, Johnson PA (2012) Vitamin D regulates anti-Mullerian hormone expression in granulosa cells of the hen. Biol Reprod 86:91CrossRefPubMed
23.
Zurück zum Zitat Rondanelli M1, Perna S, Faliva M, Monteferrario F, Repaci E, Allieri F (2014) Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena. Arch Gynecol Obstet 290(6):1079–1092 Rondanelli M1, Perna S, Faliva M, Monteferrario F, Repaci E, Allieri F (2014) Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena. Arch Gynecol Obstet 290(6):1079–1092
24.
Zurück zum Zitat Li HW, Brereton RE, Anderson RA, Wallace AM, Ho CK (2011) Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism 60:1475–1481CrossRefPubMed Li HW, Brereton RE, Anderson RA, Wallace AM, Ho CK (2011) Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism 60:1475–1481CrossRefPubMed
25.
Zurück zum Zitat Patra SK, Nasrat H, Goswami B, Jain A (2012) Vitamin D as a predictor of insulin resistance in polycystic ovarian syndrome. Diabetes Metab Syndr 6:146–149CrossRefPubMed Patra SK, Nasrat H, Goswami B, Jain A (2012) Vitamin D as a predictor of insulin resistance in polycystic ovarian syndrome. Diabetes Metab Syndr 6:146–149CrossRefPubMed
26.
Zurück zum Zitat Firouzabadi RD, Rahmani E, Rahsepar M, Firouzabadi MM (2014) Value of follicular fluid vitamin D in predicting the pregnancy rate in an IVF program. Arch Gynecol Obstet 289(1):201–206CrossRefPubMed Firouzabadi RD, Rahmani E, Rahsepar M, Firouzabadi MM (2014) Value of follicular fluid vitamin D in predicting the pregnancy rate in an IVF program. Arch Gynecol Obstet 289(1):201–206CrossRefPubMed
27.
Zurück zum Zitat Anagnostis P, Karras S, Goulis DG (2013) Vitamin D in human reproduction: a narrative review. Int J Clin Pract 67:225–235CrossRefPubMed Anagnostis P, Karras S, Goulis DG (2013) Vitamin D in human reproduction: a narrative review. Int J Clin Pract 67:225–235CrossRefPubMed
Metadaten
Titel
Prophylactic vitamin D supplementation in ovarian hyperstimulation syndrome: an animal study
verfasst von
Guluzar Arzu Turan
Fatma Eskicioglu
Oya Nermin Sivrikoz
Hakan Cengiz
Esra Bahar Gur
Sumeyra Tatar
Nur Sahin
Osman Yilmaz
Publikationsdatum
01.08.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2015
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-015-3625-1

Weitere Artikel der Ausgabe 2/2015

Archives of Gynecology and Obstetrics 2/2015 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Menopausale Hormontherapie für Frauen über 65?

07.05.2024 Klimakterium und Menopause Nachrichten

In den USA erhalten nicht wenige Frauen auch noch im Alter über 65 eine menopausale Hormontherapie. Welche positiven und negativen gesundheitlichen Konsequenzen daraus möglicherweise resultieren, wurde anhand von Versicherungsdaten analysiert.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.